Home/ Stocks/ BNTC

Benitec Biopharma Inc. Common Stock

BNTC XNAS

$12.28 -0.10 (-0.82%) ▼ 15-min delayed

Open

$12.05

High

$12.70

Low

$11.82

Volume

169.2K

Market Cap

$421.87M

About Benitec Biopharma Inc. Common Stock

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 19 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$0	$-11,837,000	$-0.26
Q1 2026	$0	$-8,965,000	$-0.22
FY 2025	$0	$-37,917,000	$-1.05
Q3 2025	$0	$-9,354,000	$-0.24

Related Market News

No specific coverage for BNTC yet. Check out our latest market news or earnings calendar.

Get BNTC Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Benitec Biopharma Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.